Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
09/2005
09/27/2005US6949544 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
09/27/2005US6949543 Amide derivative
09/22/2005WO2005087765A1 Ligands of follicle stimulating hormone receptor and methods of use thereof
09/22/2005WO2005087754A1 Substituted morpholine and thiomorpholine derivatives
09/22/2005WO2005087752A2 Substituted hydroxyethylamine aspartyl protease inhibitors
09/22/2005WO2005087750A1 Ion channel modulators
09/22/2005WO2005087748A1 Ion channel modulators
09/22/2005WO2005087747A1 Ion channel modulators
09/22/2005WO2005087746A1 Benzazepine derivatives for the treatment of neurological and psychiatric disorders
09/22/2005WO2005087740A1 Fluorenone 1, 4,-dihydropyridin derivatives
09/22/2005WO2005087725A2 Novel compounds as inhibitors of hepatitis c virus ns3 serine protease
09/22/2005WO2005087721A2 Compounds as inhibitors of hepatitis c virus ns3 serine protease
09/22/2005WO2005087710A1 Aminophenylpropanoic acid derivative
09/22/2005WO2005087235A1 Pyrrolidine compounds
09/22/2005WO2005087229A1 Ion channel modulators
09/22/2005WO2005087228A1 Ion channel modulators
09/22/2005WO2005086898A2 Inhibitors of histone deacetylase
09/22/2005WO2005086895A2 Ion channel modulators
09/22/2005WO2005086892A2 Ion channel modulators
09/22/2005WO2005073227A3 A process for the preparation of 5-[4-[2-[n-methyl-n-(2-pyridyl) amino] ethoxy] phenyl methyl] thiazolidine-2, 4-dione maleate
09/22/2005WO2005056547A3 Quinoxalines useful as inhibitors of protein kinases
09/22/2005WO2004089308A3 Di-aryl substituted pyrrole modulators of metabotropic glutamate receptor-5
09/22/2005US20050209456 Vascular endothelial growth factor; tyrosine kinase inhibitor; angiogenesis inhibitor; anticancer agents
09/22/2005US20050209292 Cancer therapy
09/22/2005US20050209291 Amino benzothiazole compounds with NOS inhibitory activity
09/22/2005US20050209290 Novel ether derivatives
09/22/2005US20050209286 RXR activating molecules
09/22/2005US20050209284 Tec kinase inhibitors
09/22/2005US20050209278 Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
09/22/2005US20050209275 Beta 2-adrenergic receptor agonists
09/22/2005US20050209274 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
09/22/2005US20050209273 Neuroprotectants, analgesics or anticonvulsants
09/22/2005US20050209260 Purinergic receptor antagonists; genitourinary and pain-related diseases; for example, 5-(2-isopropyl-4,5-dimethoxybenzyl)-pyrimidine-2,4-diamine
09/22/2005US20050209249 Use as antidiabetic agents, treating hyperglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis; (3S, 5S)-4-([5-(Thiazolidine-3-carbonyl)-pyrrolidin-3-ylmethyl]-sulfamoyl)-benzoic acid for example
09/22/2005US20050209233 Neuropeptide Y5 (NPY-5) receptor antagonists or agonists; eating disorders, diabetes dyslipidemia, hypertension, and sleep disorders; pyridazin-3-ylamino-substituted dibenzothiophenes and S-oxides thereof
09/22/2005US20050209230 2,4-Pyrimidinediamine compounds and their uses
09/22/2005US20050209226 Tetrahydroquinoline analogues as muscarinic agonists
09/22/2005US20050209224 N4-(4H-5-pyrid[1,4]oxazin-6-yl)-2,4-pyrimidinediamine derivatives; for treating rheumatoid arthritis
09/22/2005US20050209223 N-(p-(substituted 1,2,3-triazol-1-yl)phenyl) derivatives of cycloazaalkanes; particularly useful for treating methicillin-resistant Staphylococcus aureas infections
09/22/2005US20050209217 3-Mercaptopyrrolidines as farnesyl protein transferase inhibitors
09/22/2005US20050209199 Anti-sickling agents
09/22/2005US20050209164 Cyclobutenedione-containing compounds as inhibitors of hepatitis C virus NS3 serine protease
09/22/2005US20050209135 Etherification of an N-protected-2-carboxyl-4-hydroxypyrrolidine with a 4-halo-quinolone, amidation with a 1-amino-2-vinylcylcopropane, deprotecting the ring nitrogen, amidation with a 7-octenoic acid, ring closing metathesis with 2nd generation Hoveyda's catalyst; one pot process; Hepatitis C viricides
09/22/2005US20050209106 Herbicides; selectively controlling broad-leaved weeds and weed grasses in crops of useful plants; 6-ethyl-4-(4-trifluoromethyl-1H-1-pyrazolyl)-2-(2-trifluoromethylpyridin-4-yloxy)pyrimidine
09/22/2005US20050208534 Methine-substituted cyanine dye compounds
09/22/2005CA2560111A1 Aminophenylpropanoic acid derivative
09/22/2005CA2558243A1 Inhibitors of histone deacetylase
09/22/2005CA2558224A1 Ion channel modulators
09/22/2005CA2558217A1 Ion channel modulators
09/22/2005CA2558214A1 Ion channel modulators
09/22/2005CA2558036A1 Substituted hydroxyethylamine aspartyl protease inhibitors
09/22/2005CA2557904A1 Hiv integrase inhibitors
09/22/2005CA2557672A1 Ion channel modulators
09/22/2005CA2557665A1 Ion channel modulators
09/22/2005CA2557648A1 Ion channel modulators
09/22/2005CA2557642A1 Ion channel modulators
09/22/2005CA2557249A1 Novel compounds as inhibitors of hepatitis c virus ns3 serine protease
09/22/2005CA2557247A1 Compounds as inhibitors of hepatitis c virus ns3 serine protease
09/21/2005EP1577302A1 Novel ethylenediamine derivatives
09/21/2005EP1577301A1 Diamine derivatives
09/21/2005EP1577296A1 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their use
09/21/2005EP1577295A1 Process for preparing 2-oxo-1-pyrrolidine derivatives as intermediates
09/21/2005EP1575947A1 2-oxopyridin-3-yl thia(di)azole derivatives for use in the treatment of cell proliferation and apoptosis related diseases
09/21/2005EP1575946A1 Quinazoline compounds
09/21/2005EP1575940A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
09/21/2005EP1575926A1 New pyridazin-3(2h)-one derivatives
09/21/2005EP1575925A1 Novel carboxamides, the production and use thereof as medicaments
09/21/2005EP1575918A2 Substituted biaryl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators
09/21/2005EP1299382B1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
09/21/2005EP1265862B1 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
09/21/2005CN1671708A Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications
09/21/2005CN1671702A Pyridines and pyrimidines substituted by 4-trifluoromethylpyrazolyl
09/21/2005CN1671700A Substituted alkylamine derivatives and methods of use
09/21/2005CN1671684A Novel benzodioxoles
09/21/2005CN1671675A 2, 1, 3-benzothiadiazoles for use as electronic active components
09/21/2005CN1671667A Quinoline derivatives and their use as mycobacterial inhibitors
09/21/2005CN1671666A Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines
09/21/2005CN1671662A Piperidine derivative, process for producing the same, and use
09/21/2005CN1671659A Novel substituted indoles
09/21/2005CN1671421A Inclusion complexes of rosiglitazone
09/21/2005CN1671386A Substituted anilinic piperidines as MCH selective antagonists
09/21/2005CN1671380A Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors
09/21/2005CN1671379A Hydrazonopyrazole derivatives and their use as therapeutics
09/21/2005CN1671373A Compounds useful for the inhibition of ALDH
09/21/2005CN1219780C Heterocyclic compounds binding chemotactic factor receptor
09/21/2005CN1219773C Process for preparing 2-chloro-thiazole compound
09/21/2005CN1219768C Quinoline derivatives as inhibitors of MEK enzymes
09/20/2005US6946479 for treatment of microbial infections
09/20/2005US6946478 Compounds
09/20/2005US6946476 For therapy of metabolic and eating disorders such as obesity and hyperphagia, diabetes
09/20/2005US6946468 that inhibit farnesylation of mutant ras gene products; cancer; (2)-2-(2-methoxy-ethyl)-1-((cis)-3-sulfanyl-pyrrolidin-2-ylmethyl)-4-naphthoyl-piperazine
09/20/2005US6946467 Serine protease inhibitors
09/20/2005US6946462 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
09/20/2005US6946005 Pyrrolidinyl-substituted para-phenylenediamine derivatives substituted with a cationic radical, and use of these derivatives for dyeing keratin fibers
09/20/2005CA2285119C Retroviral protease inhibiting compounds
09/20/2005CA2211668C Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing the same
09/15/2005WO2005085275A1 Inhibitors of hepatitis c virus ns3 protease
09/15/2005WO2005085242A1 Novel ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus
09/15/2005WO2005085241A1 Thiazole derivative
09/15/2005WO2005085240A2 Process for the preparation of ziprasidone
1 ... 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 ... 628